傲农生物(603363.SH)发布半年度业绩，归母净利润3.61亿元，同比扭亏为盈

Core Viewpoint - Aonong Bio (603363.SH) reported a revenue of 3.957 billion yuan for the first half of 2025, reflecting a year-on-year decline of 15.01% while achieving a net profit attributable to shareholders of 361 million yuan, marking a turnaround from losses [1] Financial Performance - Revenue for the reporting period was 3.957 billion yuan, down 15.01% year-on-year [1] - Net profit attributable to shareholders was 361 million yuan, indicating a return to profitability [1] - Non-recurring net profit showed a loss of 29.74 million yuan [1] - Basic earnings per share stood at 0.14 yuan [1]